In all groups, the changes from baseline to end point in erectile function scores on the International Index of Erectile Function (IIEF-EF) and the number of patients who answered "yes" to questions 2 and 3 of the sexual encounter profile(SEP) were compared statistically. We aimed to investigate the efficacy and safety of tadalafil, aspirin, and tadalafil + aspirin combination therapy in vascular erectile dysfunction (VED).Ī total of 336 patients were randomly divided into four groups (group 1, aspirin 100 mg/day, 126 patients group 2, tadalafil 5 mg/day, 72 patients group 3, tadalafil 5 mg + aspirin 100 mg, 72 patients group 4, placebo, 66 patients).
0 kommentar(er)
